| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2874376 | The Annals of Thoracic Surgery | 2013 | 7 Pages |
Abstract
Induction chemoradiation therapy for esophageal cancer is associated with minimal perioperative and postoperative morbidity. Downstaging of clinical stage III patients undergoing induction therapy was associated with a 3- and 5-year survival benefit compared with clinical stage III patients undergoing surgery alone.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Matthew D. MD, Damien J. MD, MSc, John P. MD, James M. MD, MSCI, Benjamin D. MPH, MD, Christine L. MBA, MD, David R. MD,